Author

J.-S. Delisle

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. Cotton· 1 shared A. Obermayer· 1 shared A. Pacis· 1 shared A. Poirier· 1 shared B. Assaf· 1 shared C. Capdevielle· 1 shared C. Carli· 1 shared C. Sawchyn· 1 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Cotton

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyCell ReportsPeer-reviewedSep 1, 2023

CBFA2T3-GLIS2-dependent pediatric acute megakaryoblastic leukemia is driven by GLIS2 and sensitive to Navitoclax

M. Neault, C.-E. Lebert-Ghali, M. Fournier…·F. A. Mallette

This study identifies GLIS2 as a driver of pediatric AMKL and shows its sensitivity to navitoclax, offering a potential therapeutic strategy.

DOI 10.1016/j.celrep.2023.113084

mouseexperimental assay

𝕏 PostBluesky

ImmunologybioRxivPreprintApr 17, 2023

PTPN1/2 inhibition induces highly functional terminal effector CD8 T cells through autocrine IL-10

L. A. Perez-Quintero, A. Poirier, Z. Martinez-Cordoba…·M. L. Tremblay

This study shows that inhibiting PTPN1/2 enhances CD8 T cell effector function via autocrine IL-10, suggesting a new strategy for cancer immunotherapy.

DOI 10.1101/2023.04.17.537264

mouseexperimental assay

𝕏 PostBluesky